Katherine Cahill

GLP-1R Agonist Immune Targets in Lean and Obesity-Associated Asthma

National Institute of Allergy and Infectious Diseases · R01

Contact PI · $2.6M · Vanderbilt University Medical Center

Mechanisms by Which Glp-1 and Gip Receptor Signaling Enhance Airway Epithelial Barrier Function

National Institute of Allergy and Infectious Diseases · R21

Contact PI · $481.2K · Vanderbilt University Medical Center

Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma

National Institute of Allergy and Infectious Diseases · U01

Contact PI · $8.6M · Vanderbilt University Medical Center

The Role of Prostaglandin d2 in the Respiratory Symptoms of Aspirin Exacerbated Respiratory Disease

National Institute of Allergy and Infectious Diseases · K23

Contact PI · $951.1K · Vanderbilt University Medical Center

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

Principal investigator · Active not recruiting · Phase 2

Vanderbilt University Medical Center

Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma

Principal investigator · Withdrawn

Vanderbilt University Medical Center

Role of Inflammatory Mediators in AERD

Principal investigator · Completed

Brigham and Women's Hospital

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Site PI · Recruiting · Phase 2

Johns Hopkins University